TrialSignal
Clinical trial intelligence report
An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06692179-Jul 28, 2026
NCT ID
NCT06692179
Status
RECRUITING
Phase
PHASE1
Sponsor
University of Minnesota
Executive brief
Investment-Ready Snapshot
An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection is a PHASE1 clinical asset sponsored by University of Minnesota in Recurrent Clostridioides Difficile Infection, Colonic Surgery. SEO and diligence focus: Orally administered preparation of fecal microbiota (MTP-101P), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06692179
Indication
Recurrent Clostridioides Difficile Infection
Modality
small molecule
Target
Orally administered preparation of fecal microbiota (MTP-101P)
Intervention
Orally administered preparation of fecal microbiota (MTP-101P)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.